Provided by Tiger Trade Technology Pte. Ltd.

Biogen

225.88
-1.1900-0.52%
Post-market: 225.880.00000.00%19:30 EDT
Volume:1.55M
Turnover:352.50M
Market Cap:33.35B
PE:40.12
High:229.36
Open:227.23
Low:225.51
Close:227.07
52wk High:230.49
52wk Low:138.00
Shares:147.64M
Float Shares:147.31M
Volume Ratio:1.30
T/O Rate:1.05%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.63
EPS(LYR):8.79
ROE:4.58%
ROA:5.21%
PB:1.77
PE(LYR):25.70

Loading ...

Biogen Extends Felzartamab Kidney Rejection Trial, Bolstering Long-Term Pipeline Story

TIPRANKS
·
Aug 07

Biogen Director Lloyd Minor Disposes of 1,186 Common Shares Worth $240,351.94

Reuters
·
Aug 06

Biogen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 05

Biogen price target raised to $241 from $221 at Mizuho

TIPRANKS
·
Aug 04

From Products to Innovation: Three Emerging Sectors Anchor China's Economic Growth in 2025

Deep News
·
Aug 04

Stoke Therapeutics Q2 Revenue Falls 33% on Lower Collaboration, Licensing Income

Reuters
·
Aug 04

Biogen is Maintained at Neutral by Citigroup

Dow Jones
·
Aug 04

Mizuho Securities Keeps Their Buy Rating on Biogen (BIIB)

TIPRANKS
·
Aug 03

Biogen : Citigroup Raises Target Price to $215 from $200

THOMSON REUTERS
·
Aug 03

Stifel Nicolaus Remains a Buy on Biogen (BIIB)

TIPRANKS
·
Aug 03

Biogen Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Aug 01

Moderna Posts Smaller-than-expected Q2 Loss Per Share on Lower R&D Spending

Reuters
·
Jul 31

Biogen, Inc : H.c. Wainwright Raises Target Price to $251 from $237

THOMSON REUTERS
·
Jul 30

Biogen is Maintained at Neutral by Wedbush

Dow Jones
·
Jul 30

Biogen price target lowered to $240 from $242 at RBC Capital

TIPRANKS
·
Jul 30

Alnylam Q2 Revenue Rises 67% on Increased Demand for Amvuttra

Reuters
·
Jul 30

Phathom Pharmaceuticals Q2 Revenue Beats on Voquezna Prescription Growth

Reuters
·
Jul 30

Madrigal Pharmaceuticals Q2 Revenue Rises 71% on Rezdiffra Demand

Reuters
·
Jul 30

Regeneron Q2 Revenue Beats on Higher Dupixent, Eylea HD Sales

Reuters
·
Jul 30

Agios Q2 Revenue Jumps on US Commercial Launch of Aqvesme

Reuters
·
Jul 30